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Abstract. After primary infection , varicella-zoster virus (VZV) becomes latent in 
ganglia. VZV reactivation occurs primarily in elderly individuals, organ transplant 
recipients , and patients with cancer and AIDS , correlating with a specific decl ine in cell-
mediated immunity to VZV. VZV can also reactivate after surgical stress. To determine 
whether VZV can also reactivate after acute non-su rgical stress, we examined total 
DNA extracted from 312 saliva samples of eight astronauts before, during and after 
space flight for VZV DNA by PCR: 112 samples were obtained 234 to 265 days before 
fl ight, 84 samples on days 2 through 13 of space flight , and 116 samples on days 1 
through 15 after flight. Before space flight only one of the 112 saliva samples from a 
single astronaut was positive for VZV DNA. In contrast, during and after space flight , 61 
of 200 (30%) saliva samples were positive in all 8 astronauts. No VZV DNA was 
detected in any of 88 saliva samples from 10 healthy control subjects. These data 
indicate that VZV can reactivate subclinically in healthy individuals after acute stress. 
Introduction. Primary VZV infection typically causes childhood varicella (chickenpox), 
after which virus becomes latent in cranial nerve, dorsal root and autonomic ganglia 
along the entire human neuraxis. Virus reactivates primarily in elderly individuals, as 
well as in organ transplant recipients and in patients with cancer and AIDS. 
Reactivation correlates with a specific decline in cell-mediated immunity to VZV. 
Although VZV also reactivates after the stress of surgery, including orofacial surgery, 
the relationship of VZV reactivation to non-surgical stress has not been studied. 
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Space flight provides a model of acute, non-surgical stress, involving a unique and 
unfamiliar environment, together with sudden gravitational changes associated with 
launch and landing, and the critical requirement for precise actions. In fact , measurable 
acute stress responses , such as increased urinary cortisol and interleukin-6 levels, have 
been demonstrated during launch and reentry (Stein and Schluter, 1994). Here, we 
describe our analysis of saliva samples from eight astronauts (three missions) before, 
during and after space flight for evidence of VZV reactivation. The samples were coded 
for blinded polymerase chain reaction (peR) analysis for VZV DNA in two separate 
laboratories. We also collected serum samples and compared the anti-VZV IgG titer of 
astronauts to matched controls . 
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MATERIALS AND METHODS 
Subjects. Eight astronauts (seven men and one woman) , 37 to 51 years of age (mean , 
42.7 yr) during three space shuttle missions , 10 to 12 days in duration were studied. 
Before flight , all astronauts were seropositive for VZV. Ten healthy individuals in the 
same age range served as controls. The study was approved by the Johnson Space 
Center Institutional Review Board. 
Sample Collection. Saliva samples were collected from each astronaut, before, during 
and after flight , on cotton rolls (Salivette kits , Sarstedt Inc., Newton, NC) , stored in 
polypropylene vials containing 1.0 ml storage buffer (1 % sodium dodecyl sulfate, 10 mM 
Tris-HCI , pH 8.0, 1 mM EDTA) , and coded for blinded PCR analysis as described 
(Payne et ai. , 1999). Baseline (preflight) samples were collected on arising every other 
day for 1 month , beginning approximately 6 months before launch. Daily in-flight saliva 
samples were collected throughout the mission. Post-flight samples were collected on 
landing day and then daily for 2 weeks. Control saliva samples were collected every 
other day for 4 weeks. Blood samples were collected from 10 days before flight and 2 
to 3 hours after landing. Two blood samples were collected 22 days apart from five 
control subjects. Th is collection schedule closely approximated the pre- and post-flight 
collection schedule during a 12-day flight. Serum was obtained and stored at -70QC 
until processed. 
DNA Extraction and peR. Saliva specimens were concentrated with a Microsep 100K 
filtration unit (Filtron Technology Corporation , Northborough, MA) , and DNA was 
extracted with nonorganic extraction reagents (Qiagen Inc., Chatsworth , CA). 
Microcarrier gel (Molecular Research Center, Inc., Cincinnati , OH) was added to 
facilitate DNA recovery (Boehringer Mannheim, Indianapolis, IN). DNA was dissolved in 
50 I-li of nuclease-free water (Amresco , Solon , OH) . 
Qualitative nested PCR was performed on a 1/25 (2 1-l1) of the extracted DNA using VZV 
ORF 63-specific primers (Cohrs et ai. , 1996). Amplified DNA was resolved on agarose 
gels, stained with ethid ium bromide and the image was captured digitally. Quantitative 
real -time PCR was performed in a TaqMan 7700 sequence detector (Perkin Elmer 
Biosystems) using fluorescence-based simultaneous amplification and product 
detection. Primers and probes for VZV gene 63 and for glyceraldehyde 6-phosphate 
dehydrogenase (GAPdH) DNA sequences were as described (Cohrs et ai. , 2000) . 
Antiviral Antibody Assay. IgG antibody against VZV was determined by enzyme 
immunoassay (EIA) (Forghani et ai. , 1986). Each serum sample was tested at a 1 :200 
dilution against viral antigen (VA) , a lysate prepared from VZV-infected human diploid 
lung cells , and against control antigen (CA) , a lysate prepared from uninfected cells at 
the same passage level. Data generated by EIA were expressed as optical density 
index (001) , defined as the absorbance value of VA minus the absorbance value of CA 
divided by the cut-off (CO) value. CO is defined as the mean absorbance of a large 
number of VZV-seronegative samples. An 001 of ~ N.M was considered positive for the 
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presence of VZV-specific IgG. An 001 of <1.0 was considered negative for the 
presence of VZV-specific IgG, and may indicate no prior exposure to the virus. 
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Statistical Analysis. PCR results were analyzed using logistic regression with random 
subject effects via SAS Proc NLMIXED (SAS, 1999) to determine outcome significance . 
Assuming independence and binominal distribution, the probability of detecting VZV 
DNA was determined by the following formula: 
where Pijk is the probability of VZV DNA detection, Li is the detection method (i=1 for 
nested PCR, i=2 for real-time PCR) , Tj is the effect of the time (j=1 preflight, j=2 for 
during flight , j=3 for post-flight) , and Sk identifies the ith subject. The (L T)ij terms are 
detection method by time interactions. 
Results 
Frequency of VZV DNA detection in saliva before, during and after space flight. 
Nested PCR analyses was periormed on DNA extracted from 312 saliva samples from 
eight astronauts. Figure 1 A shows a representative gel after amplification of 40 saliva 
samples; 13 were positive for VZV DNA. Serial 10glO dilutions of purified VZV DNA 
revealed that nested PCR could detect one copy of target VZV DNA. Figure 1 B shows 
representative results of the real-time PCR assay. Regression analysis indicated that 
the PCR assay was linear (R2=0.96) over a 10glO range of VZV DNA from 101 to 104 
copies. 
Table 1 summarizes the PCR detection of VZV DNA in saliva samples taken before, 
during, and after space flight. Yellow rectangles indicate samples negative for VZV 
DNA by both techniques, nested and real time PCR. Green rectangles indicate saliva 
samples positive for VZV DNA by nested PCR, but negative by real time PCR. Blue 
rectangles indicate saliva samples positive for VZV DNA by real time PCR, but negative 
by nested PCR. Red rectangles indicate saliva samples positive for VZV DNA by both 
techniques , nested and real time PCR. Numbers within blue and red rectangles denote 
the VZV DNA copy number determined by real time PCR. Before flight , all 112 samples 
(14 from each of eight astronauts over a 6-month period) were negative for VZV DNA by 
real-t ime PCR, while nested PCR detected VZV DNA in one sample from a single 
subject. Of 84 saliva samples collected from the eight astronauts during flight , 12 
samples (14%) revealed VZV DNA in nested PCR assays, while 14 samples (16%) 
were positive for VZV DNA in real-time PCR; 4 saliva samples from three astronauts 
were positive for VZV DNA in both real-time and nested PCR. Overall , VZV DNA was 
detected in six of the eight astronauts (75%) from 23 of 84 (27%) saliva samples 
obtained during flight. Analysis of a total of 116 saliva samples collected daily for 15 
days after flight revealed VZV DNA in 23 (19%) samples by nested-PCR, and in 20 
(17%) samples by real-time PCR; 4 samples from four astronauts were positive by both 
real-time and nested PCR. Thus, 38 of 116 (32%) saliva samples were positive for VZV 
DNA in all eight (100%) astronauts for 2 weeks after landing . None of 88 saliva 
samples collected from 10 healthy control subjects was positive for VZV DNA by either 
nested or real-time PCR. 
Technique (nested PCR vs . real-time PCR) did not affect the detection of VZV DNA 
either additively (p = 0.1671) or interactively (p=0.441) . However, the frequency of 
detection of VZV DNA was significantly greater during and after flight than before flight 
whether nested PCR (p<0.0098 during and p<0.0060 after). The copy number of 
GAPdH DNA did not differ significantly in the saliva samples collected from astronauts 
before (22 ± 6.3, mean, ±SEM), during (21 .5±5.9) and after space flight (20.9 ± 4.9) or 
in control subjects (22.5 ± 4.3) by real-time PCR (ANOVA, p=0.925). 
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Serum anti-VZV IgG in control subjects and astronauts. Serum anti-VZV IgG 001 
were determined in five control subjects and in six astronauts 10 days before flight and 
again 2 to 3 hours after landing. The 001 for one control serum sample was <1 
indicating no previous exposure to VZV, and therefore was dropped from the analysis. 
In the remaining 8 samples from 4 control subjects , the average anti-VZV IgG 001 was 
5.8 ± 0.5, as compared with 14.9 ± 1.1 in 12 serum specimens from six astronauts. 
After accounting for two samples on each subject via analysis of variance, the average 
anti-VZV IgG 001 for astronauts (14.9 ± 1.1 , k=2 samples on each of n=6 astronauts) 
was significantly higher (F-test, p=0.01) than the average IgG 001 for controls (5 .8 ± 
0.5, k=2 samples on each of n=4 controls). In each of the six astronauts and 5 
controls , there was no significant difference in the anti-VZV IgG titer 10 days before 
flight compared to that after landing . Unfortunately, serum samples from astronauts 
weeks to months before or after space flight were not available for analysis . 
Discussion 
Using a convenient, non-invasive method of detecting amplifiable VZV DNA from 
human saliva, this study showed an association between VZV reactivation and acute, 
nonsurgical stress in healthy individuals . Detection of VZV DNA in saliva has been 
used previously to establish an association between VZV reactivation and facial palsy, 
Ramsay Hunt syndrome (facial palsy and zoster oticus) and zoster sine herpete (pain 
without rash) (Furuta et aI. , 2000a; 2000b; 2001). In those disorders, real-time PCR 
revealed considerable day-to-day variation in VZV DNA copy number, consistent with 
our find ings in the astronauts examined. In fact , the low concordance between our 
nested PCR and real-time PCR results , based on a correlation coefficient of 0.16, might 
reflect sampling variation , low VZV DNA copy number or loss of DNA during storage or 
shipment. However, PCR results grouped according to time of sampling (before, during 
and after flight) revealed a high concordance between the two PCR methods. 
Of interest, we also found a two to three-fold increase in circulating anti-VZV IgG in 
astronauts compared to control subjects. Because we were unable to obtain a second 
serum specimen from astronauts weeks to months after space flight, it was not possible 
to demonstrate a significant change in antibody to VZV. For example, a four-fold rise 
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and fall in antibody to VZV has been used as evidence of subclinical VZV reactivation in 
both immunocompromised and immunocompetent individuals (Arvin et aL , 1983; 
Gershon et aL , 1984; Schunemann et aL , 1998). However, the combination of VZV 
DNA in saliva and a higher specific antibody response in serum of the astronauts 
compared to control subjects further confirms subclinical reactivation of VZV. 
Two other human herpesviruses, cytomegalovirus and Epstein-Barr virus, have also 
been shown to reactivate during and after space flight (Mehta et aL, 2000; Payne et aL , 
1999). Although the mechanism by which herpesviruses reactivate during space fl ight 
is unknown, the combination of gravitational changes and a confined , unfamiliar 
environment (extreme isolation from family in a crowded environment, lack of privacy, 
sleep depravation , micro-gravity, physical and physiological stress) has been 
associated with increased levels of ACTH and cortisol during and after space flight 
(Stowe et aL , 2000; 2001 a; 2001 b). Multiple clinical reports also support a role for 
steroids in zoster. For example, a steroid-dependent asthmatic patient who received 
two courses of high-dose intravenous methylprednisolone at a time when she was 
exposed to chickenpox developed classic varicella with complications (Silk et aI. , 1988). 
Another study reported four patients who received steroids and developed zoster with 
an average incubation period of 18 days (Rado et aI. , 1965). Further, in a study of six 
zoster patients with preherpetic neuralgia (prolonged pain before rash) , two who had 
been taking long-term, low-dose steroids developed disseminated skin lesions with 
neurologic complications of zoster paresis and a fatal zoster encephalitis , respectively 
(Gilden et aL , 1991). Finally, steroid therapy in the week before or after VZV 
vaccination has been associated with an increased incidence of varicella rash (Lydick et 
aI. , 1989). While additional experiments are needed to determine how stress-induced 
hormonal changes lead to human herpesvirus reactivation , this study adds VZV to the 
list of human herpesviruses that reactivate in response to acute nonsurgical stress. 
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Figure legend 
Figure 1. Detection of VZV DNA in astronaut saliva. Total DNA was extracted from 
the saliva of astronauts and 312 samples were coded for blinded PCR analysis. Panel 
A shows a representative gel after nested-PCR for VZV DNA in 40 saliva samples . The 
presence of VZV DNA is demonstrated by the amplification of a 300-bp VZV-specific 
DNA fragment (arrow). Each set of PCRs contained seriallog1 0 dilutions of purified 
VZV DNA, indicating that nested PCR could detect 1 (IOg lO 0) copy of VZV DNA. 
Negative controls without template DNA (No DNA) were always negative for VZV DNA. 
Panel B shows a representative graph of results from real time PCR analysis of 20 
sal iva DNA samples. Each real-time PCR contained serial log10 dilutions of purified 
VZV DNA (filled circles) that were used to quantitate the VZV DNA in saliva (open 
circles). The number of cycles required to detect VZV DNA within each sample 
(threshold cycle) was inversely related to the initial amount of VZV DNA present in the 
sample. Real-time PCR assay is linear (regression analysis , R2=0.96) over a range of 
10glO VZV DNA from 101 to 104 copies. Reaction mixtures containing no template DNA 
were always negative for VZV DNA (not shown). 
Table 1 legend. 
Yellow rectangles indicate samples negative for VZV DNA by both techniques , nested 
and real time PCR. Green rectangles indicate saliva samples positive for VZV DNA by 
nested PCR, but negative by real time PCR. Blue rectangles indicate saliva samples 
positive for VZV DNA by real time PCR, but negative by nested PCR. Red rectangles 
indicate saliva samples positive for VZV DNA by both techniques , nested and real time 
PCR. White rectangles indicate days for which no saliva sample was available (n.a., 
not available). Numbers within blue and red rectangles denote the VZV DNA copy 
number determined by real time PCR. VZV DNA was detected in 1 % of 112 samples 
collected before flight , 27% of 84 samples collected during flight , and 33% of 116 
samples collected after flight. 
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Table 1. Frequency of VZV DNA in astronaut saliva before, during and after 
space flight (summary of nested and real-time peR results). 
Subject 
Days 1 2 3 4 5 6 7 
Before 265 
flight 263 
261 
259 
255 
253 
249 
247 
243 
241 
239 
237 
236 
234 
During 2 110 
flight 3 <10 
4 
5 
6 <10 
7 <10 
~ ~ <10 9 <10 <10 10 25-,-000 <10 
11 
12 no sample available, flight terminated <10 
13 
After flight 1 <10 n.a. <10 220 
2 n.a. <10 
3 n.a. 
4 330 
5 24 
6 
7 190 
8 280 
9 
10 2100 
11 
12 440 
13 
~ 14 15 
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12 
8 
<10 
55 
600 
5500 
